Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
2834
https://www.incyte.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corp
Health Care Roundup: Market Talk
- May 13th, 2024 9:24 pm
Incyte Stock Marks Biggest Jump in 7 Years on ‘Dutch Auction’ Buyback Plan. How It Works.
- May 13th, 2024 2:57 pm
Incyte Launches $1.67 Billion Share Repurchase 'Dutch Auction' Tender Offer; to Buy Back $328 Million of Baker Entities' Shares
- May 13th, 2024 12:24 pm
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
- May 13th, 2024 11:00 am
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
- May 12th, 2024 12:26 pm
Incyte First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- May 4th, 2024 2:36 pm
Q1 2024 Insight Enterprises Inc Earnings Call
- May 3rd, 2024 3:17 am
Incyte to Present at Upcoming Investor Conference
- May 2nd, 2024 12:00 pm
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
- May 1st, 2024 3:12 pm
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
- Apr 30th, 2024 3:50 pm
Incyte misses quarterly profit on weak sales of lead drug
- Apr 30th, 2024 2:10 pm
Incyte (INCY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- Apr 30th, 2024 1:30 pm
Incyte Corp (INCY) Q1 2024 Earnings: Misses Revenue Estimates but Shows Strong Growth in ...
- Apr 30th, 2024 12:34 pm
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
- Apr 30th, 2024 11:00 am
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
- Apr 26th, 2024 12:25 pm
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
- Apr 25th, 2024 6:28 pm
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 24th, 2024 2:01 pm
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
- Apr 23rd, 2024 2:01 pm
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
- Apr 23rd, 2024 1:44 pm
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
- Apr 23rd, 2024 11:00 am
Scroll